Revive Therapeutics Announces Update on its Collaboration Agreement with Health Canada Licensed Dealer for …

TORONTO, ONTARIO–(Marketwired – Jan. 4, 2018) – Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV)(OTCQB:RVVTF), a company focused on the research, development and commercialization of novel therapies and technologies for the medical cannabis and cannabinoid-based pharmaceutical markets, today announced an update on the Company’s collaboration agreement with Chemi Pharmaceutical Inc. (“Chemi Pharma”), a Licensed Dealer for cannabis pursuant to the Controlled Drugs and Substances Act under Health Canada and its assistance with the decentralization of services enabled by blockchain technology to be integrated and utilized for the benefit of medical cannabis patients.

“Our collaboration with Chemi Pharma is an important part of our strategy in commercializing novel cannabis-based therapies and partnering with licensed producers of medical cannabis in Canada and the U.S.,” said Craig Leon, Chief Executive Officer of Revive. “Revive is also evolving its concept of a patient-focused platform enabled by blockchain that integrates structured and unstructured data

... read more at:


Leave a Reply

Your email address will not be published. Required fields are marked *